RecruitingNCT06851975

Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

Sponsor

Centre Antoine Lacassagne

Enrollment

40,000 participants

Start Date

Jan 7, 2020

Study Type

OBSERVATIONAL

Conditions

Research into biomarkers predictive of survival and response to cancer treatment

Min Age: 18 Years

Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care,
Patient who has read the information note and stated that he/she has no objections
Patient who has not objected to the use of this data for medical research purposes
Patient with social security cover.

Patient already included in the study
Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8

Interested in this trial?

Get notified about updates and connect with the research team.

OTHERblood sampling

36ml of blood will be taken during a blood sampling performed in standard practice

Centre Antoine Lacassagne

Nice, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT06851975